Clinical Trial Update: Immune Biomarker Study for Salivary Gland Carcinoma

View source ↗

Summary

An ongoing immune biomarker study at University of Erlangen-Nürnberg Medical School is investigating immune biomarkers in salivary gland carcinoma and related s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Salivary Gland Tumor
• Salivary Gland Carcinoma

Snippet

Sponsor: University of Erlangen-Nürnberg Medical School | Conditions: Salivary Gland Tumor, Benign Salivary Gland Tumor | Status: RECRUITING